These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22149314)

  • 1. Dronedarone: a new hope for stroke prevention in atrial fibrillation?
    Shantsila A; Lip GY
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):355-6. PubMed ID: 22149314
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
    Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH;
    Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
    Krishnamoorthy S; Lip GY
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):473-81. PubMed ID: 19419255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dronedarone: a review of characteristics and clinical data.
    Baroletti S; Catella J; Ehle M; Cheng JW
    Crit Pathw Cardiol; 2010 Jun; 9(2):94-101. PubMed ID: 20520217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dronedarone for atrial fibrillation: How does it compare with amiodarone?
    Penugonda N; Mohmand-Borkowski A; Burke JF
    Cleve Clin J Med; 2011 Mar; 78(3):179-85. PubMed ID: 21364162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dronedarone establishes and maintains control of sinus rhythm].
    Schwender T
    Rev Med Suisse; 2006 Aug; 2(76):1902-3. PubMed ID: 16972539
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of atrial fibrillation complications with antiarrhythmic drugs: still an unmet need in clinical practice.
    Dobrev D
    Expert Opin Pharmacother; 2011 Jun; 12(8):1195-1199. PubMed ID: 21548721
    [No Abstract]   [Full Text] [Related]  

  • 8. Dronedarone for atrial fibrillation therapy.
    Marzocchi M; Lombardi F
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):675-83. PubMed ID: 21714598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new agent for atrial fibrillation: electrophysiological properties of dronedarone.
    Singh BN; Cingolani E
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):6S-14S. PubMed ID: 21098415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials.
    Duray GZ; Schmitt J; Hohnloser SH
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):19S-23S. PubMed ID: 20472812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial fibrillation: outpatient presentation and management.
    Ezekowitz MD; Aikens TH; Nagarakanti R; Shapiro T
    Circulation; 2011 Jul; 124(1):95-9. PubMed ID: 21730322
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission.
    Naccarelli GV; Wolbrette DL; Samii S; Banchs JE; Penny-Peterson E; Gonzalez MD
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):24S-30S. PubMed ID: 21098416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.
    Pamukcu B; Lip GY
    Expert Opin Pharmacother; 2010 Dec; 11(17):2775-8. PubMed ID: 21050033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice.
    Pamukcu B; Lip GY
    Expert Opin Pharmacother; 2011 Jan; 12(1):131-40. PubMed ID: 21126199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dronedarone--a new therapeutic option for controlling atrial rhythm and ventricular frequency].
    Klein HH
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35 Suppl 4):S113-7. PubMed ID: 16921447
    [No Abstract]   [Full Text] [Related]  

  • 16. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
    Singh BN; Connolly SJ; Crijns HJ; Roy D; Kowey PR; Capucci A; Radzik D; Aliot EM; Hohnloser SH;
    N Engl J Med; 2007 Sep; 357(10):987-99. PubMed ID: 17804843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug evaluation: dronedarone, a novel non-iodinated anti-arrhythmic agent.
    Sablayrolles S; Le Grand B
    Curr Opin Investig Drugs; 2006 Sep; 7(9):842-9. PubMed ID: 17002263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dronedarone odyssey.
    Prescrire Int; 2010 Aug; 19(108):150. PubMed ID: 20939440
    [No Abstract]   [Full Text] [Related]  

  • 19. Dronedarone and the incidence of stroke in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis of randomized trials.
    Dagres N; Varounis C; Iliodromitis EK; Lekakis JP; Rallidis LS; Anastasiou-Nana M
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):395-400. PubMed ID: 22149318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dronedarone: in quest of the ideal antiarrhythmic drug.
    Kayser SR
    Prog Cardiovasc Nurs; 2007; 22(4):221-4. PubMed ID: 18059201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.